UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049095
Receipt number R000055915
Scientific Title Study to verify the effect of continuous intake of test foods on skin condition: single group open study
Date of disclosure of the study information 2022/10/05
Last modified on 2023/01/06 13:22:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study to verify the effect of continuous consumption of the test food on improving skin condition

Acronym

Skin condition improvement efficacy verification tests

Scientific Title

Study to verify the effect of continuous intake of test foods on skin condition: single group open study

Scientific Title:Acronym

Skin condition improvement efficacy validation study: single group open study

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the study is to examine the effect of the test food on the skin condition after 6 weeks of continuous consumption.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin lightness, hue, saturation

Key secondary outcomes

Dark circles status score, skin condition questionnaire, stratum corneum moisture content, skin viscoelasticity (R2, R5, R7), skin texture


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Consume the test food once a day after dinner with water or lukewarm water for 6 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

65 years-old >=

Gender

Female

Key inclusion criteria

1. Japanese nationals
2. healthy women over 40 and under 65 years of age
3. who are concerned about dark circles under the eyes

Key exclusion criteria

1. Persons with skin diseases such as atopic dermatitis, contact dermatitis or skin hypersensitivity
2. Persons taking medication or applying medication externally to the study site that is thought to affect the study within 2 weeks of the start of the study
3. Persons with scars or sunburn at the test site that would interfere with the determination
4. Persons with a history of treatment for malignancy, heart failure or myocardial infarction
5. Persons under treatment for the following chronic diseases
Atrial fibrillation, arrhythmia, liver disorders, renal disorders, cerebrovascular disorders, rheumatism, diabetes, dyslipidaemia, hypertension and other chronic diseases
6. Persons who regularly use pharmaceuticals (including herbal medicines), foods for specified health uses, functional foods, health foods and supplements
7. Persons with allergies (to medicines and test food related foods)
8. Persons who are pregnant, lactating or intend to become pregnant during the study period
9. Persons who are participating in a human trial at the start of the study or who are expected to participate in another human trial during the planned duration of the study
10. Any other person who is deemed by the investigator to be unsuitable for the study

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Igari

Organization

Daiwa Pharmaceutical Co., Ltd.

Division name

Research and Development Department

Zip code

154-0024

Address

1-16-19 Sangenjaya, Setagaya-ku, Tokyo, Japan

TEL

03-5430-4050

Email

igari@daiwa-pharm.com


Public contact

Name of contact person

1st name Masao
Middle name
Last name Matsuoka

Organization

M&I Science CORP.

Division name

Clinical Development Department

Zip code

531-0071

Address

NAKATSUGRAND Bld.10F, 1-17-26, Nakatsu, Kita-ku, Osaka-Shi, Osaka, Japan

TEL

06-7878-6780

Homepage URL


Email

m.matsuoka@mis21.co.jp


Sponsor or person

Institute

M&I Science CORP.

Institute

Department

Personal name



Funding Source

Organization

Daiwa Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NISHI-UMEDA Clinic for Asian Medical Collaboration Clinical Research Institutional Review Board

Address

West Umeda Building 3F 3-3-45 Umeda Kita-ku Osaka Japan, 530-0001

Tel

06-4797-5660

Email

jimukyoku@amc-clinc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 08 Month 19 Day

Date of IRB

2022 Year 09 Month 22 Day

Anticipated trial start date

2022 Year 10 Month 06 Day

Last follow-up date

2022 Year 11 Month 17 Day

Date of closure to data entry

2022 Year 12 Month 16 Day

Date trial data considered complete

2022 Year 12 Month 20 Day

Date analysis concluded

2023 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 10 Month 03 Day

Last modified on

2023 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055915


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name